104 related articles for article (PubMed ID: 35461158)
1. A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects.
Xu Z; Wang Y; Liu Z; Zhang R; Zhou Y; Yu J; Lan J; Liang W; Liu G; Qu X; Chen J; Su Z; Yu S; Cheng Y; Wang W; Ren Q; Deng Q; Zhao Y; Yang H
Int Immunopharmacol; 2022 Aug; 109():108780. PubMed ID: 35461158
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioequivalence of tofacitinib 5 mg in healthy Korean male subjects.
Lee JH; Jeon JY; Jang K; Kang SK; Kwak YG; Moon SJ; Kim MG
Int J Clin Pharmacol Ther; 2024 Mar; 62(3):142-148. PubMed ID: 38174885
[TBL] [Abstract][Full Text] [Related]
3. A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif
Liu G; Xue J; Wang Y; Liu Z; Li X; Qu D; Su Z; Xu K; Qu X; Qu Z; Sun L; Cao M; Wang Y; Chen X; Yu J; Liu L; Deng Q; Zhao Y; Zhang L; Yang H
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2585-2593. PubMed ID: 35771264
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of tofacitinib citrate bioequivalence based on pharmacokinetic parameters in healthy Chinese subjects.
Yu B; Wang X; Yang Y; Lu C; Hu W; Zhang X
Int J Clin Pharmacol Ther; 2021 Apr; 59(4):343-352. PubMed ID: 33433317
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Bioequivalence of 2 Immediate-Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B; Feng J; Huang L
Clin Pharmacol Drug Dev; 2021 May; 10(5):535-541. PubMed ID: 32770665
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects.
Shin W; Yang AY; Yun H; Cho DY; Park KH; Shin H; Kim A
Transl Clin Pharmacol; 2020 Sep; 28(3):160-167. PubMed ID: 33062629
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditions.
Liu Z; Xu Z; Gao Z; Ren Q; Chang T; Xue J; Yang H
Invest New Drugs; 2023 Feb; 41(1):60-69. PubMed ID: 36441437
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X; Zhong G; Yao H; Wu J; Ye S
Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Bioequivalence of Cefprozil for Suspension and Granule Formulation in Healthy Chinese Volunteers: Two Single-Dose Crossover Studies.
Lin PP; Wang CJ; Liu YP; Li T; Gao XM; Ma YP; Shi P; Li X; Wang LX; Cao Y
Adv Ther; 2021 Feb; 38(2):1130-1142. PubMed ID: 33340343
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditions.
Li T; Liu YP; Liu SQ; Shi P; Jiang X; Tao Y; Gao XM; Ma YP; Cao Y
BMC Pharmacol Toxicol; 2022 Jul; 23(1):45. PubMed ID: 35794660
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects.
Liu Z; Gao Z; Yang W; Zhang L; Xiao N; Qu D; Su Z; Xu K; Liu G; Wang Y; Ren Q; Yu S; Cheng Y; Zhou Y; Deng Q; Zhao Y; Wang Z; Yang H
Expert Opin Drug Metab Toxicol; 2022; 18(7-8):519-527. PubMed ID: 35961948
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
Li C; Xu J; Zheng Y; Chen G; Wang J; Ma L; Qiao Y; Niu J; Wu M; Zhang H; Li X; Chen H; Zhu X; Liu C; Ding Y
Chem Pharm Bull (Tokyo); 2017 Jun; 65(6):524-529. PubMed ID: 28392509
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers.
Liu MY; Wang S; Yao WF; Wu HZ; Meng SN; Wei MJ
Clin Ther; 2009 Apr; 31(4):784-92. PubMed ID: 19446151
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and bioequivalence study of emtricitabine/tenofovir disoproxil fumarate tablets in healthy Chinese subjects
.
Lu C; Yang Y; Zhang Q; Zhou R; Liu Z; Hu W
Int J Clin Pharmacol Ther; 2019 Dec; 57(12):623-632. PubMed ID: 31549623
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioequivalence of a generic empagliflozin tablet versus a brand-named product and the food effects in healthy Chinese subjects.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B
Drug Dev Ind Pharm; 2020 Sep; 46(9):1487-1494. PubMed ID: 32799565
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers.
Kim SH; Park YS; Kim JM; Park HJ; Lee MH; Park HK; Kim YJ; Cho SH; Shaw LM; Kang JS
Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755
[TBL] [Abstract][Full Text] [Related]
20. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
Elshafeey AH; Elsherbiny MA; Fathallah MM
Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
